9 September 2020 · This Q&A provides advice on the legal considerations required when considering mixing medicines to be supplied or administered under a PGD
6 March 2017 · The posted documents are proceedings of the NHS Pharmaceutical Quality Assurance Committee. They are advice notes written to address issues which have arisen in previous…
8 September 2020 · NICE guidance providing good practice recommendations for individual people and organisations involved with the development, authorisation and use PGDs.
10 June 2021 · The below summary explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off-label')
8 January 2020 · The below summary details the legal position regarding the sale, supply or administration of off-label/ unlicenced products under Schedule 17 of the HMR 2012
24 May 2010 · This guidance document is based on an information developed by the London & SE QA Group and guidance documents produced by Quality Control North West. This…
16 November 2016 · The purpose of this document is to provide detailed guidance on the pharmaceutical quality assessment of unlicensed medicines. The principles are applicable both to unlicensed…
10 June 2020 · The following Q&A is intended to be read as a complete document to help provide the full context in practice. In this document the term…
19 January 2021 · The record retention requirements for COVID-19 vaccinations administered under a Patient Specific Direction reflect the national record keeping standards.
11 March 2016 · In 1972 Hospital Technical Memorandum No. 22 (HTM 22) was published ‘Piped Medical Gases, Medical Compressed Air and Vacuum Installations’ as a direct result of…